Zhi Liu, PhD, is the Corresponding Author of this study and a Professor and Doctoral Supervisor at the School of Life Science and Technology, Huazhong University of Science and Technology (HUST), Wuhan, China. He obtained his BS and PhD degrees in Microbiology from Nanjing Agricultural University and completed postdoctoral training at HUST, followed by long-term research appointments at the University of Pennsylvania School of Medicine. Dr. Liu’s research centers on microbe–host interactions, gut microbiota–mediated regulation of immunity and metabolism, microbial cultivation and synthetic microbiome engineering, and the translational development of probiotics and live biotherapeutic products. He has published over 90 peer-reviewed articles in high-impact journals, including Cell Host & Microbe, Advanced Science, eLife, Gut Microbes, ISME Journal, Nucleic Acids Research, and PLOS Pathogens. He is a recipient of the National Science and Technology Progress Award (Second Class) of China and has led multiple nationally funded projects supported by the Ministry of Science and Technology and the National Natural Science Foundation of China. Dr. Liu currently serves as Associate Editor of Global Journal of Microbiology, Editorial Board Member of Frontiers and BMC Microbiology, and holds leadership roles in several national professional societies related to microbiology, oncology, and microecology.
Zhi Liu, PhD, is the Corresponding Author of this study and a Professor and Doctoral Supervisor at the School of Life Science and Technology, Huazhong University of Science and Technology (HUST), Wuhan, China. He obtained his BS and PhD degrees in Microbiology from Nanjing Agricultural University and completed postdoctoral training at HUST, followed by long-term research appointments at the University of Pennsylvania School of Medicine. Dr. Liu’s research centers on microbe–host interactions, gut microbiota–mediated regulation of immunity and metabolism, microbial cultivation and synthetic microbiome engineering, and the translational development of probiotics and live biotherapeutic products. He has published over 90 peer-reviewed articles in high-impact journals, including Cell Host & Microbe, Advanced Science, eLife, Gut Microbes, ISME Journal, Nucleic Acids Research, and PLOS Pathogens. He is a recipient of the National Science and Technology Progress Award (Second Class) of China and has led multiple nationally funded projects supported by the Ministry of Science and Technology and the National Natural Science Foundation of China. Dr. Liu currently serves as Associate Editor of Global Journal of Microbiology, Editorial Board Member of Frontiers and BMC Microbiology, and holds leadership roles in several national professional societies related to microbiology, oncology, and microecology.